Two German companies, Mahle GmbH and Schott Pharma AG, are exploring initial public offerings of their Indian businesses that could raise as much as $400 million each, according to people familiar with the matter, as multinational firms seek to tap the premium valuations commanded by their locally listed peers.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.